Correlation Between Amylyx Pharmaceuticals and Dogwood Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Dogwood Therapeutics,, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Dogwood Therapeutics,.

Diversification Opportunities for Amylyx Pharmaceuticals and Dogwood Therapeutics,

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amylyx and Dogwood is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Dogwood Therapeutics, go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Dogwood Therapeutics,

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 0.78 times more return on investment than Dogwood Therapeutics,. However, Amylyx Pharmaceuticals is 1.28 times less risky than Dogwood Therapeutics,. It trades about 0.01 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about -0.03 per unit of risk. If you would invest  1,422  in Amylyx Pharmaceuticals on September 2, 2024 and sell it today you would lose (868.00) from holding Amylyx Pharmaceuticals or give up 61.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Dogwood Therapeutics,

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Dogwood Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Amylyx Pharmaceuticals and Dogwood Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Dogwood Therapeutics,

The main advantage of trading using opposite Amylyx Pharmaceuticals and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.
The idea behind Amylyx Pharmaceuticals and Dogwood Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.